Application

17973714 · PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS

Filed 2022-10-26 · Granted · Patent 12544365 (2026-02-10) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Sagar S Patel Typical · CPC A61K 31/438 · ROTTAPHARM BIOTECH S.R.L · ELMORE PATENT LAW GROUP, PC

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

23.1 mo

to disposition 39.5 mo

Statutes raised

103 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.